aspirin has been researched along with prazosin in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (12.12) | 18.7374 |
1990's | 9 (27.27) | 18.2507 |
2000's | 12 (36.36) | 29.6817 |
2010's | 8 (24.24) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, KS; Ko, FN; Teng, CM; Wu, YC | 1 |
Chen, KS; Ko, FN; Teng, CM; Wu, TS; Wu, YC | 1 |
Chang, YL; Chen, IS; Chen, TL; Lin, WY; Teng, CM | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aranyi, Z; Ballagi-Pordány, G; Hadházy, P; Koltai, MZ; Pogátsa, G; Rösen, P | 1 |
Fujiwara, M; Kurahashi, K; Taniguchi, T; Tsukahara, T; Usui, H | 1 |
Godfraind, T; Schoeffter, P | 1 |
Conti, CR | 1 |
Fujiwara, M; Fukui, K; Kurahashi, K; Shirahase, H; Usui, H | 1 |
Gulati, A; Rebello, S | 1 |
Bilello, K; Cole, F; Jaffin, J; Malcolm, D; Powell, C; Schultz, S | 1 |
Gulati, A; Sharma, AC | 1 |
Bertolino, F; Fauré, P; John, GW; Valentin, JP; Vieu, S | 1 |
Dube, SN; Gupta, AK; Kaushik, MP; Kumar, D; Mazumder, PK | 1 |
Callingham, BA; Davidson, HJ; Hiley, CR; Ho, WS; Ritchie, AJ; Vuylsteke, A; White, R | 1 |
Anesini, C; Borda, E; Coussio, J; Ferraro, G; Turner, S | 1 |
Gokee, A; Rocchini, AP; Yang, JQ | 1 |
Ong, CT; Sung, SF; Tong, SH; Wu, CS | 1 |
Cheng, FY; Lü, HX; Zhang, ZH; Zhou, JP | 1 |
2 review(s) available for aspirin and prazosin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Large vessel coronary vasospasm: diagnosis, natural history and treatment.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aspirin; Coronary Artery Bypass; Coronary Disease; Coronary Vasospasm; Diltiazem; Electrocardiography; Epoprostenol; Female; Fibrinolytic Agents; Humans; Isosorbide Dinitrate; Male; Nifedipine; Nitrates; Prazosin; Verapamil | 1985 |
31 other study(ies) available for aspirin and prazosin
Article | Year |
---|---|
Antiplatelet of vasorelaxing actions of some benzylisoquinoline and phenanthrene alkaloids.
Topics: Alkaloids; Animals; Aorta, Thoracic; Female; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Rabbits; Rats; Vasodilator Agents | 1996 |
Bioactive alkaloids from Illigera luzonensis.
Topics: Alkaloids; Animals; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Plant Stems; Plants, Medicinal; Platelet Aggregation Inhibitors; Rabbits; Rats | 1997 |
Chemical constituents and biological activities of the fruit of Zanthoxylum integrifoliolum.
Topics: Animals; Aorta; Chromatography, Thin Layer; Furans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Philippines; Plants, Medicinal; Platelet Aggregation Inhibitors; Rabbits; Rats; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Taiwan; Vasodilation | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Disturbed lipid metabolism in diabetic coronary vessels.
Topics: Alloxan; Animals; Arachidonic Acids; Aspirin; Coronary Circulation; Coronary Vessels; Diabetes Mellitus, Experimental; Dogs; Epoprostenol; Female; Indomethacin; Male; Microcirculation; Myocardium; Norepinephrine; Phentolamine; Prazosin; Prostaglandin-Endoperoxide Synthases; Receptors, Adrenergic, alpha; Thromboxane A2; Vasoconstriction | 1992 |
Differences in contractile responses to electrical stimulation and alpha-adrenergic binding sites in isolated cerebral arteries of humans, cows, dogs, and monkeys.
Topics: Animals; Aspirin; Cattle; Cerebral Arteries; Dogs; Electric Stimulation; Female; Humans; In Vitro Techniques; Macaca; Norepinephrine; Phentolamine; Prazosin; Receptors, Adrenergic, alpha; Serotonin; Species Specificity; Vasoconstriction; Yohimbine | 1985 |
Spontaneous rhythmic contractions of human saphenous veins isolated from old subjects are sensitive to cyclooxygenase inhibitors.
Topics: Adult; Aged; Aging; Aspirin; Coronary Artery Bypass; Cyclooxygenase Inhibitors; Female; Histamine; Humans; In Vitro Techniques; Indomethacin; Male; Middle Aged; Muscle Contraction; Muscle Development; Muscle, Smooth; Nifedipine; Norepinephrine; Phentolamine; Prazosin; Pyrilamine; Saphenous Vein | 1989 |
Endothelium-dependent vasocontraction in response to noradrenaline in the canine cerebral artery.
Topics: Animals; Aspirin; Cerebral Arteries; Dogs; Endothelium; Female; In Vitro Techniques; Male; Methacrylates; Norepinephrine; Prazosin; Serotonin; Thromboxane A2; Thromboxane-A Synthase; Vasoconstriction; Yohimbine | 1987 |
Diaspirin cross-linked hemoglobin (DCLHB): involvement of adrenergic mechanisms in the pressor effect.
Topics: Adrenal Medulla; Adrenalectomy; Animals; Aspirin; Blood Pressure; Blood Substitutes; Clonidine; Drug Interactions; Hemoglobins; Male; Phenylephrine; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Yohimbine | 1994 |
Diaspirin crosslinked hemoglobin (DCLHb): control of pressor effect with anti-hypertensive agents.
Topics: Animals; Antihypertensive Agents; Aspirin; Blood Pressure; Blood Substitutes; Hemoglobins; Hypertension; Labetalol; Nicardipine; Nitroglycerin; Prazosin; Rats | 1994 |
Prazosin blocks the pressor but not the regional circulatory effects of diaspirin crosslinked hemoglobin.
Topics: Animals; Aspirin; Blood Pressure; Drug Interactions; Hemodynamics; Hemoglobins; Male; Prazosin; Rats; Rats, Sprague-Dawley; Regional Blood Flow | 1994 |
Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Carotid Arteries; Carotid Stenosis; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart Rate; Hemodynamics; Hydrazines; Jugular Veins; Ketanserin; Male; Oxadiazoles; Piperazines; Platelet Aggregation; Prazosin; Rabbits; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Prostaglandin; Receptors, Serotonin; Receptors, Thromboxane; Ritanserin; Serotonin Antagonists; Stress, Mechanical | 1997 |
Cardiovascular effects of an organophosphate toxin isolated from Ptychodiscus brevis.
Topics: Adrenergic alpha-Antagonists; Animals; Aspirin; Atropine; Cardiovascular System; Cholinesterase Inhibitors; Cimetidine; Dinoflagellida; Dose-Response Relationship, Drug; Drug Interactions; Ganglionic Blockers; Hexamethonium; Histamine H2 Antagonists; Humans; Male; Marine Toxins; Muscarinic Antagonists; Neostigmine; Organophosphorus Compounds; Platelet Aggregation Inhibitors; Potassium Channels; Prazosin; Rats; Rats, Wistar; Vasoconstriction | 1997 |
Effect of the blood substitute diaspirin crosslinked hemoglobin in rat mesenteric and human radial collateral arteries.
Topics: Animals; Antihypertensive Agents; Arteries; Aspirin; Blood Substitutes; Bucladesine; Carbachol; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hemoglobins; Humans; In Vitro Techniques; Male; Mesenteric Arteries; Methoxamine; Middle Aged; Muscle Contraction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptides, Cyclic; Prazosin; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Effect of Larrea divaricata Cav. extract and nordihydroguaiaretic acid upon peroxidase secretion in rat submandibulary glands.
Topics: 3,3'-Diaminobenzidine; Animals; Argentina; Aspirin; Atenolol; Butoxamine; Dinoprostone; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Female; Forecasting; Larrea; Masoprocol; Peroxidase; Plant Extracts; Plant Leaves; Prazosin; Propranolol; Rats; Rats, Wistar; Submandibular Gland; Water | 2004 |
Hypertension and insulin resistance are not directly related in obese dogs.
Topics: Adrenergic beta-Antagonists; Animals; Aspirin; Atenolol; Blood Glucose; Clonidine; Diet, Sodium-Restricted; Dietary Fats; Dogs; Female; Furosemide; Hemodynamics; Hypertension; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Models, Animal; Models, Biological; Obesity; Prazosin; Protein Serine-Threonine Kinases; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathetic Nervous System | 2004 |
Multiple cerebral infarctions related to famotidine-induced eosinophilia.
Topics: Acarbose; Adrenergic alpha-1 Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cerebral Infarction; Diabetes Mellitus, Type 2; Diffusion Magnetic Resonance Imaging; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Famotidine; Humans; Hypertension; Hypoglycemic Agents; Labetalol; Male; Metformin; Middle Aged; Nifedipine; Peptic Ulcer; Prazosin; Sulfonylurea Compounds | 2012 |
[The effects and its mechanism of N-arginine chitosan as transdermal enhancer].
Topics: Administration, Cutaneous; Animals; Arginine; Aspirin; Cell Line; Cell Survival; Cell-Penetrating Peptides; Chitosan; Drug Carriers; Humans; Isosorbide Dinitrate; Keratinocytes; Male; Mice; Prazosin; Skin Absorption | 2013 |